tizanidine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 64980-659
  • Package NDC 64980-659-03
  • Package NDC 64980-659-10
  • Package NDC 64980-659-15
  • Application number ANDA218920
  • SPL ID 356b3e79-d47b-467a-af62-2adca35f1a2f
  • SPL set ID 433ac98f-ac22-44ad-a8b4-5db5560b9d0f
  • UNII B53E3NMY5C
  • RxCUI 313412
  • RxCUI 313413

What the source publishes

Labeler
Rising Pharma Holdings, Inc.
Active ingredients
tizanidine
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:64980-659_356b3e79-d47b-467a-af62-2adca35f1a2f
{
  "name": "tizanidine",
  "splId": "356b3e79-d47b-467a-af62-2adca35f1a2f",
  "labels": [
    {
      "setId": "433ac98f-ac22-44ad-a8b4-5db5560b9d0f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=433ac98f-ac22-44ad-a8b4-5db5560b9d0f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=433ac98f-ac22-44ad-a8b4-5db5560b9d0f"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Rising Pharma Holdings, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (64980-659-03)",
      "package_ndc": "64980-659-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241215"
    },
    {
      "sample": false,
      "description": "1000 TABLET in 1 BOTTLE (64980-659-10)",
      "package_ndc": "64980-659-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241215"
    },
    {
      "sample": false,
      "description": "150 TABLET in 1 BOTTLE (64980-659-15)",
      "package_ndc": "64980-659-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20241215"
    }
  ],
  "productId": "64980-659_356b3e79-d47b-467a-af62-2adca35f1a2f",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "64980-659",
  "deaSchedule": null,
  "genericName": "tizanidine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TIZANIDINE HYDROCHLORIDE",
      "strength": "4 mg/1"
    }
  ],
  "applicationNumber": "ANDA218920",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20241215",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "B53E3NMY5C"
    ],
    "rxcui": [
      "313412",
      "313413"
    ],
    "spl_set_id": [
      "433ac98f-ac22-44ad-a8b4-5db5560b9d0f"
    ],
    "manufacturer_name": [
      "Rising Pharma Holdings, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:64980-659_356b3e79-d47b-467a-af62-2adca35f1a2f"